http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H045266-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e29e759d65b7e915908ffc01c56b2c6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-52
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-08
filingDate 1990-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f914153ccca7474f80610170dce408c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72d52dc880ab4a313472be3526f56c47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3d1ebaf241446dae828c086fa35bf2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c596b82a3fd8233d4bffab4874a736fb
publicationDate 1992-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H045266-A
titleOfInvention Production of dopamine derivative
abstract PURPOSE: To industrially advantageously obtain the subject compound by reacting an ethylamine derivative corresponding to the aimed compound with a butane-2-one derivative in the presence of a boron cyanated sodium hydride catalyst and subjecting resultant new intermediate to demethylation. n CONSTITUTION: A compound expressed by formula I is reacted with a compound expressed by formula II in an organic solvent, preferably alcoholic solvent, etc., and in the presence of a boron cyanated sodium hydride catalyst to obtain a new substance expressed by formula III. Next, the new substance is subjected to demethylation in a normal method and further an acid is added, as necessary, to afford the aimed compound expressed by formula IV or acid-added salt of the compound useful for treating abruptly depressed cardiac contraction with a few processes and simple and safe process in high yield. Besides, to the compound expressed by formula II, the compound expressed by formula I is preferably used as equimolar to 8 times mol, especially 4-6 times mol and the catalyst is preferably used as equimolar to 5 times mol, especially equimolar to two times mol. n COPYRIGHT: (C)1992,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9796672-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11691947-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10611728-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9346114-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9815770-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014524482-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11214540-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10207991-B2
priorityDate 1990-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448056355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559585

Total number of triples: 34.